In the SCALE Diabetes trial, participants with type 2 diabetes were given either 1.8 mg of liraglutide, 3 mg of liraglutide, or a placebo. Those taking 3 mg of liraglutide lost 6% of their body weight, those taking 1.8 mg lost 4.7%, and those on the placebo lost 2%. Compounding pharmacies offer customized semaglutide, but…